Iprazid
Iprazid Uses, Dosage, Side Effects, Food Interaction and all others data.
Withdrawn from the Canadian market in July 1964 due to interactions with food products containing tyrosine.
Iprazid is a monoamine oxidase inhibitor (MAOI) that was developed as the first anti-depressant.
Trade Name | Iprazid |
Generic | Iproniazid |
Iproniazid Other Names | Iproniazid, Iproniazida, Iproniazide, Iproniazidum |
Type | |
Formula | C9H13N3O |
Weight | Average: 179.219 Monoisotopic: 179.105862053 |
Groups | Withdrawn |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Uses
For the treatment of depression (originally intended to treat tuberculosis).
Innovators Monograph
You find simplified version here Iprazid